Currently, same-day delivery is available only in Dallas, Chicago, New York City, Gainesville, Miami, Tampa, and Fort Lauderdale; this program will be expanded in 2019.
Researchers administered a survey to 160 physicians attending an educational session related to deprescribing.
Evidence allowing us to assess the benefits of and risks associated with prescription drug monitoring programs is insufficient.
In adults age 50 or older, higher education, illicit drug use, depression, and pain interference with normal work are significantly associated with opioid misuse.
Results showed that 65% of those in the intervention group underestimated their opioid prescribing.
Researchers examined the frequency of overpayments by comparing copayments with the national average reimbursements received by pharmacies for the same prescription for commercially insured patients.
Pharmacist feedback and education is effective at reducing prescription writing errors by junior doctors in an inpatient setting.
Implementation of electronic medical record default opioid prescriptions of 10 tablets of 5 mg oxycodone/325 mg acetaminophen at discharge from the ED may be associated with an increased percentage of prescriptions for 10 tablets, compared with no default.
For older patients discharged from a regional hospital, there are frequently discrepancies between the electronic discharge summaries and the National Inpatient Medication Chart or discharge prescription.
Implementation of an enhanced recovery after surgery protocol resulted in an increase in opioid-free anesthesia and multimodal analgesia, but did not modify opioid prescribing practices.
Nocebo hyperalgesia was stronger when the treatment was labeled as an expensive medication versus a cheap medication.
The Food and Drug Administration, in partnership with Interpol, has cracked down on over 500 websites that illegally sell potentially dangerous, unapproved medications to US consumers.
At the pharmacy level, a greater emphasis will be placed on counseling to help patients understand the risks associated with opioid use based on the new Centers for Disease Control and Prevention (CDC) guidelines.
One physician shares his insights on the culture of overprescribing medications and how prescribing habits are reflective of swindling by the pharmaceutical industry
Long-term opioid prescription use increased threefold during a 16-year period between 1999 and 2014.
Some physicians are creating new ways to work around the rising costs of prescription medications.
At PAINWeek, Dr Hah focused on the risks of long-term opioid use for chronic noncancer pain and reviewed guidelines regarding the tapering of these medications.
Market competition levels are associated with changes in the price of generic drugs.
After a comprehensive initiative to curb opioid prescribing, researchers identified reductions in all tracked outcomes, including a 30% decrease in prescribing opioids at high doses.
Errors are common in opioid medication prescriptions, and most often happen in handwritten prescriptions.
Health insurers are recruiting former pharmaceutical company representatives to educate doctors and help save money on prescription medications.
Many patients cannot identify the intended meaning of United States Pharmacopeia pictograms.
For adolescents, medical and nonmedical use of prescription opioids has declined in recent years.
Medicare patients treated by higher-spending physicians are just as likely to be re-admitted or die within 30 days of being admitted as those treated by low-precribing physicians.
The researchers found that novice prescribers cited insufficient access to substance abuse counseling for patients, as well as insufficient access to more experienced prescribers, as reasons for not treating more patients.
The risk of long-term opioid use can be reduced by prescribing a short-acting painkiller with no refills.
The more drugs taken, the higher the risk of adverse events.
Renewing all patient's stable medications for 12 to 15 months can save time and money.
Clinical Pain Advisor Articles
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Business Degree Increasingly Useful for Doctors
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Manual Therapy vs Opioids for Management of Shoulder, Spine Pain
- Greater Temporal Summation of Pain in HIV With Chronic Pain
- FDA Warns Two Companies About Bogus Opioid Addiction Treatment
- Prescription Digital Therapeutic Approved for Opioid Use Disorder
- A Potential Biomarker for Predicting Antibody Treatment Efficacy in Migraine